Los Angeles Capital Management
CLVS

Los Angeles Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Los Angeles Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,194
Closed -$241K – 1414
2018
Q3 		$241K Sell
8,194
-41,655
-84% -$1.61M ﹤0.01% 1286
2018
Q2 		$2.27M Buy
49,849
+14,025
+39% +$682K 0.01% 659
2018
Q1 		$1.89M Buy
35,824
+14,485
+68% +$845K 0.01% 649
2017
Q4 		$1.45M Buy
21,339
+9,521
+81% +$666K 0.01% 760
2017
Q3 		$974K Buy
+11,818
New +$937K 0.01% 827

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Los Angeles Capital Management's CLVS Position: Q4 2018 in Review

Los Angeles Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 8,194 shares — an estimated $241K sold.

Los Angeles Capital Management first reported a position in CLVS in Q3 2017 and held it in 5 quarters. The position peaked at $2.27M in Q2 2018. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • Los Angeles Capital Management reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • Los Angeles Capital Management sold 8,194 Clovis Oncology, Inc. shares in Q4 2018, an estimated $241K.
  • Los Angeles Capital Management first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 5 quarters.
  • Los Angeles Capital Management's Clovis Oncology, Inc. position peaked at $2.27M in Q2 2018.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Los Angeles Capital Management's 13F filing for Q4 2018, filed 11 Feb 2019.